Publications | Lund University Publications

1 – 10 of 21

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Vergote%2C+Ignace%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Vergote%2C+Ignace%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2024
Mark Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Vergote, Ignace ; Gonzalez-Martin, Antonio ; Fujiwara, Keiichi ; Kalbacher, Elsa ; Bagameri, Andrea ; Ghamande, Sharad ; Lee, Jung Yun ; Banerjee, Susana ; Maluf, Fernando Cotait and Lorusso, Domenica , et al. (2024) In New England Journal of Medicine 391(1). p.44-55
- Contribution to journal › Article
2021
Mark European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma
Concin, Nicole ; Planchamp, François ; Abu-Rustum, Nadeem R. ; Ataseven, Beyhan ; Cibula, David ; Fagotti, Anna ; Fotopoulou, Christina ; Knapp, Pawel ; Marth, Christian and Morice, Philippe , et al. (2021) In International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31(12). p.1508-1529
- Contribution to journal › Article
2020
Mark The LACC Trial and Minimally Invasive Surgery in Cervical Cancer
Vergote, Ignace ; Magrina, Javier F. ; Zanagnolo, Vanna ; Magtibay, Paul M. ; Butler, Kristina ; Gil-Moreno, Antonio ; Feijoo, Berta Diaz ; Kimmig, Rainer ; Canis, Michel and Bourdel, Nicholas , et al. (2020) In Journal of Minimally Invasive Gynecology 27(2). p.462-463
- Contribution to journal › Debate/Note/Editorial
Mark Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively : multicentre cohort study
Van Calster, Ben ; Valentin, Lil ^LU ; Froyman, Wouter ; Landolfo, Chiara ; Ceusters, Jolien ; Testa, Antonia C. ; Wynants, Laure ; Sladkevicius, Povilas ^LU ; Van Holsbeke, Caroline and Domali, Ekaterini , et al. (2020) In BMJ (Clinical research ed.) 370.
- Contribution to journal › Article
2019
Mark Risk of complications in patients with conservatively managed ovarian tumours (IOTA5) : a 2-year interim analysis of a multicentre, prospective, cohort study
Froyman, Wouter ; Landolfo, Chiara ; De Cock, Bavo ; Wynants, Laure ; Sladkevicius, Povilas ^LU ; Testa, Antonia Carla ; Van Holsbeke, Caroline ; Domali, Ekaterini ; Fruscio, Robert and Epstein, Elisabeth ^LU , et al. (2019) In The Lancet Oncology 20(3). p.448-458
- Contribution to journal › Article
2016
Mark Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas
Froyman, Wouter ; Landolfo, Chiara ; Amant, Frédéric ; Van den Bosch, Thierry ; Vergote, Ignace ; Coosemans, An ; Testa, Antonia ; Valentin, Lil ^LU ; Bourne, Tom and Calster, Ben Van , et al. (2016) In The Lancet Oncology 17(3). p.4-273
- Contribution to journal › Debate/Note/Editorial
Mark Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis (IOTA) group.
Timmerman, Dirk ; Van Calster, Ben ; Testa, Antonia ; Savelli, Luca ; Fischerova, Daniela ; Froyman, Wouter ; Wynants, Laure ; Van Holsbeke, Caroline ; Epstein, Elisabeth and Franchi, Dorella , et al. (2016) In American Journal of Obstetrics and Gynecology 214(4). p.424-437
- Contribution to journal › Article
Mark Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)
Kurzeder, Christian ; Bover, Isabel ; Marḿe, Frederik ; Rau, Joern ; Pautier, Patricia ; Colombo, Nicoletta ; Lorusso, Domenica ; Ottevanger, Petronella ; Bjurberg, Maria ^LU and Marth, Christian , et al. (2016) In Journal of Clinical Oncology 34(21). p.25-2516
- Contribution to journal › Article
Mark Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
Bois, Andreas du ; Kristensen, Gunnar ; Ray-Coquard, Isabelle ; Reuss, Alexander ; Pignata, Sandro ; Colombo, Nicoletta ; Denison, Ursula ; Vergote, Ignace ; Del Campo, Jose M and Ottevanger, Petronella , et al. (2016) In The Lancet Oncology 17(1). p.78-89
- Contribution to journal › Article
Mark No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
Hollestelle, Antoinette ; Van Der Baan, Frederieke H. ; Berchuck, Andrew ; Johnatty, Sharon E. ; Aben, Katja K. ; Agnarsson, Bjarni A. ; Aittomäki, Kristiina ; Alducci, Elisa ; Andrulis, Irene L. and Anton-Culver, Hoda , et al. (2016) In Gynecologic Oncology 141(2). p.386-401
- Contribution to journal › Article

« previous
1
2
3
next »

your query:: Remove author: Vergote, Ignace